Home » New Hair Loss Treatments Pipeline » Samumed
Detailed information on the research project currently underway. We encourage you to bookmark these pages and check back often. Updates will be added periodically with new information on status, newly-released data, and clinical trial results. Back to New Hair Loss Research Pipeline
SM04554 is a topical compound that modulates the WNT pathway. The WNT pathway is one of the primary signalling pathways that regulate the self-renewal and differentiation of adult stem cells. It also plays other important roles: from hair follicle cycling to hair follicle morphogenesis.
Samumed believes that the ability to modulate the WNT pathway can present a significant opportunity for the treatment of Androgenetic Alopecia, resulting in more hair growth.
Redefining Health Through Tissue Regeneration
10-01-16: Samumed Includes Hair Loss in Regenerative Medicine Platform